In vitro efficacy of antimalarial drugs against circulating strains of the SARS-CoV-2 virus that causes COVID-19 in Panama.
- Funded by Secretaría Nacional de Ciencia, Tecnología e Innovación (SENACYT)
- Total publications:0 publications
Grant number: COVID19-041
Grant search
Key facts
Disease
COVID-19Known Financial Commitments (USD)
$200,000Funder
Secretaría Nacional de Ciencia, Tecnología e Innovación (SENACYT)Principal Investigator
Dr. Nicanor Tercero Obaldía RodríguezResearch Location
PanamaLead Research Institution
Instituto Conmemorativo Gorgas de Estudios de la Salud (ICGES)Research Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Prophylactic use of treatments
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable